Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2013
Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysisB A M Heemskerk-Gerritsen, M B E Menke-Pluijmers, A Jager, et al.
Breast Cancer Research and Treatment|October 24, 2007
Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patientsMieke Kriege, Caroline Seynaeve, Hanne Meijers-Heijboer, et al.
Annals of Surgical Oncology|June 2, 2007
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer ClinicBernadette A M Heemskerk-Gerritsen, Cecile T M Brekelmans, Marian B E Menke-Pluymers, et al.
International Journal of Cancer|January 8, 2013
Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer riskMadeleine M A Tilanus-Linthorst, Hester F Lingsma, D Gareth Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Survival and prognostic factors in BRCA1-associated breast cancerC T M Brekelmans, C Seynaeve, M Menke-Pluymers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Hereditary Cancer in Clinical Practice|April 3, 2009
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomyMurly B M Tan, Eveline M A Bleiker, Marian B E Menke-Pluymers, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2005
Hereditary breast cancer growth rates and its impact on screening policyMadeleine M A Tilanus-Linthorst, Mieke Kriege, Carla Boetes, et al.
Breast Cancer Research and Treatment|June 29, 2002
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)Litanja N Lodder, Petra G Frets, R Willem Trijsburg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2017
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Maartje J Hooning, et al.
Pageof 6